Navigation Links
Methane-powered laptops may be closer than you think
Date:11/23/2010

Making fuel cells practical and affordable will not happen overnight. It may, however, not take much longer.

With advances in nanostructured devices, lower operating temperatures, and the use of an abundant fuel source and cheaper materials, a group of researchers led by Shriram Ramanathan at the Harvard School of Engineering and Applied Sciences (SEAS) are increasingly optimistic about the commercial viability of the technology.

Ramanathan, an expert and innovator in the development of solid-oxide fuel cells (SOFCs), says they may, in fact, soon become the go-to technology for those on the go.

Electrochemical fuel cells have long been viewed as a potential eco-friendly alternative to fossil fuelsespecially as most SOFCs leave behind little more than water as waste.

The obstacles to using SOFCs to charge laptops and phones or drive the next generation of cars and trucks have remained reliability, temperature, and cost.

Fuel cells operate by converting chemical energy (from hydrogen or a hydrocarbon fuel such as methane) into an electric current. Oxygen ions travel from the cathode through the electrolyte toward the anode, where they oxidize the fuel to produce a current of electrons back toward the cathode.

That may seem simple enough in principle, but until now, SOFCs have been more suited for the laboratory rather than the office or garage. In two studies appearing in the Journal of Power Sources this month, Ramanathan's team reported several critical advances in SOFC technology that may quicken their pace to market.

In the first paper, Ramanathan's group demonstrated stable and functional all-ceramic thin-film SOFCs that do not contain any platinum.

In thin-film SOFCs, the electrolyte is reduced to a hundredth or even a thousandth of its usual scale, using densely packed layers of special ceramic films, each just nanometers in thickness. These micro-SOFCs usually incorporate platinum electrod
'/>"/>

Contact: Caroline Perry
cperry@seas.harvard.edu
617-496-1351
Harvard University
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Myth of a germ-free world: A closer look at antimicrobial products
2. New clinical test to predict lupus flares moves closer to the market
3. Scientists closer to grasping how the brains hearing center spurs responses to sound
4. 1 step closer to a drug treatment for cystic fibrosis, MU professor says
5. Plant scientists move closer to making any crop drought-tolerant
6. Solid oxide fuel cells getting closer to the market
7. Gene therapy a step closer to mass production
8. Research is getting closer to understanding critical nucleus in haze formation, prof says
9. Genome BC, Chile and Norway take another step closer to fully sequencing the salmon genome
10. Low-cost, ultra-fast DNA sequencing brings diagnostic use closer
11. For osteoporosis patients, exercise pill one step closer to reality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... known for a long time that some creatures evolve ... particularly for plants. But it may be that height ... University and the U. S. National Evolutionary Synthesis Center. ... May in the journal Nature Communications , Lanfear ... , Drawing from a database of global patterns in ...
(Date:5/21/2013)... considered in the management of natural resources, and ... help them recognize and respond to the relationships ... , Place-Based Conservation: Perspectives from the Social ... Northwest Research Station,s Linda Kruger, can help managers ... is published by Springer Verlag and is available ...
(Date:5/21/2013)... in the body, stem cells in the blood ... into mature immune cells that can fight off ... these cell populations, potentially leading to the development ... a team of researchers led by biologists at ... that, in mouse models, the molecule microRNA-146a (miR-146a) ...
Breaking Biology News(10 mins):Small but speedy: Short plants live in the evolutionary fast lane 2Keeping stem cells strong 2
... This release is available in Spanish . , ... of Radiology and Physical Medicine of the University ... of Public Health (Escuela Andaluza de Salud Pblica), found ... of persistent organic compound (POCs), substances internationally classified as potentially ...
... finds that a chemical found in the body is capable ... in an animal model. The hormone is gastric inhibitory polypeptide ... is a peptide hormone that is secreted in response to ... insulin as part of the digestive process in response to ...
... PITTSBURGH Practice makes perfect or at least thats ... of multiplication tables, goal kicks and piano scales ... many, to be true. Thats why neuroscientists have ... of individual synapses, or connections between neurons, increased, repetitive ...
Cached Biology News:100 percent of people carry at least 1 type of pesticide 2100 percent of people carry at least 1 type of pesticide 3Human hormone blocker found to help prevent obesity and diabetes: study 2Human hormone blocker found to help prevent obesity and diabetes: study 3Novel mechanism for long-term learning identified by Carnegie Mellon researchers 2Novel mechanism for long-term learning identified by Carnegie Mellon researchers 3
(Date:5/23/2013)... Calif. , May 23, 2013  Saddleback Memorial ... recently became the first hospital on the West ... technology. This new surgical option provides women with a ... Marc Winter , M.D., a ... and surgeon and medical director of minimally invasive surgery ...
(Date:5/23/2013)... May 23, 2013 Northwest Biotherapeutics (NASDAQ: ... DCVax ® personalized immune therapies for solid tumor ... at this year,s American Society Of Clinical Oncology (ASCO) ... its leadership role in immune therapy.  (Logo: ... meeting is the pre-eminent conference focused on clinical treatment ...
(Date:5/23/2013)... , May 23, 2013 Pusan National ... a private biotherapeutics and contract research company focused ... for cancer, announced today a publication reporting the ... with the oncolytic and immunotherapeutic vaccinia JX-594 (pexastimogene ... was published in the May 15 th , ...
(Date:5/23/2013)... Louis, Missouri (PRWEB) May 23, 2013 ... and manufacture of complete thermal systems, recently introduced ... than 90 years of experience in designing and ... complete selection of products to serve diverse customer ... options is featured at the beginning of the ...
Breaking Biology Technology:Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 2Saddleback Memorial Surgeon First on the West Coast to Perform Single-Site Robotic Hysterectomy 3NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 2NW Bio Exhibit at the Upcoming ASCO Meeting to Highlight its Leadership Role in Immune Therapy for Cancer 3Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 2Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment 3Watlow Introduces Its New Industrial Heater Catalog 2
... IBD with Novel Mode of ActionMOUNTAIN VIEW, Calif., ... announced that data from the company,s PROTECT-1 (the ... Trial) Phase II/III clinical trial of Traficet-EN(TM) (CCX282-B) ... presented in an oral session at the upcoming ...
... Technologies & Bioressources Inc. ("Neptune") (NASDAQ.NEPT - TSX.V.NTB) ... fiscal year ended February 28, 2009. Neptune reports ... three-month period ended February 28, 2009. Neptune and ... Neptune reports consolidated operating results for its nutraceutical ...
... saves time for reprint buyers by integrating the quote ... Calif., May 19 Reprints Desk, Inc., the content ... Reprints NRx for the Force.com AppExchange from salesforce.com ... the AppExchange is a procurement service that enables buyers ...
Cached Biology Technology:ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 2ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 3ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 4ChemoCentryx's Traficet-EN(TM) Phase II/III Induction Phase Data in Crohn's Disease to be Featured in Oral Presentation at 2009 Digestive Disease Week 5Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 2Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 3Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 4Neptune Technologies Reports Fiscal 2009 Results - Record revenue and profitability growth in nutraceutical business 5Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 2Reprints Desk Medical Reprint Service Now Available to Life Science Professionals on the Force.com AppExchange 3